AssetMark’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
AssetMark's INSM Position: Q3 2026 in Review
AssetMark reduced its Insmed (INSM) stake by 22% in Q3 2026, selling an estimated $915K and leaving 27,100 shares worth $3.09M. The position accounts for 0.01% of the portfolio, ranked #845.
AssetMark first reported a position in INSM in Q1 2022 and has held it in 19 quarters since. The position peaked at $6.91M in Q4 2025. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.
- AssetMark held 27,100 shares of Insmed worth $3.09M as of Q3 2026.
- AssetMark sold 7,771 Insmed shares in Q3 2026, an estimated $915K.
- Insmed made up 0.01% of AssetMark's portfolio in Q3 2026, its #845 holding.
- AssetMark first reported a position in Insmed in Q1 2022 and has held it in 19 quarters since.
- AssetMark's Insmed position peaked at $6.91M in Q4 2025.
- 547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.